A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more ...

A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more ...

A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more effective drugs for human leishmaniasis, a parasitic disease that afflicts ...

1 Health and Environment Laboratory, Hassan II University of Casablanca, Biochemistry, Biotechnology and Immunophysiopathology Research Team, Ain Chock Faculty of Sciences, Casablanca, Morocco 2 ...

Tropical diseases are still neglected. Over 1 million of new cases of leishmaniasis are detected globally every year. In Kenya, community mobilizer and doctors try to make communities aware about ...

The legacy of our ancient human relatives, "brain-eating-amoeba" infections, emerging viral threats, the promise and peril of ...

The London-based Alphabet-owned lab will work with the Drugs for Neglected Diseases initiative (DNDI) to treat Chagas disease ...

Prof. Charles Chunge is a distinguished medical professional, researcher, and academic with a career spanning nearly five ...

A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more effective drugs for human leishmaniasis, a parasitic disease that ...